Sym023 is a human monoclonal antibody (mAb) that targets TIM-3/HAVCR2/CD366. It enhances immune stimulation and exhibits anti-tumor activity, making it a valuable research tool for studies on non-small cell lung cancer, solid tumors, and lymphoma.
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted
